Top Stories

The U.S. Food and Drug Administration released a Drug Safety Communication on July 20, 2021, concerning the removal of the strongest warning against using statins during pregnancy. The warning states that statins should never be used in any patients during pregnancy.

The window for nominations to NLA and Chapter leadership positions is now open through February 28, 2021. Open positions include: 

National Lipid Association positions include:

• At-Large Board Member (up to 7)

Chapter positions include:

• President-Elect
• Treasurer
• Secretary
• At-Large Board Member (up to 5)

For more information and to nominate your colleagues, visit www.lipid.org/nominate.

Esperion has announced that NEXLIZET™ (bempedoic acid and ezetimibe) Is now available in pharmacies in the United States. NEXLIZET™ is an oral, once-daily, fixed-dose combination tablet indicated as an adjunct to diet and maximally tolerated statin for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or established atherosclerotic cardiovascular disease (ASCVD) who require additional lowering of LDL-C.